Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A combined neuronal extracellular vesicle-haematology panel for clinical stratification of Alzheimer's disease and dementia.

Metabolic brain disease·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Switching and its Impact on Perseveration in a Verbal Fluency Task: a Study in Persons With Alzheimer's Clinical Syndrome.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2025
Same author

Neuropsychological application of the International Test Commission Guidelines for Translation and Adapting of Tests.

Journal of the International Neuropsychological Society : JINS·2024
Same author

Universal and Language-Specific Connected Speech Characteristics of Bilingual Speakers With Alzheimer's Disease: Insights From Case Studies of Structurally Distinct Languages.

Journal of speech, language, and hearing research : JSLHR·2024
Same author

Illiterate Addenbrooke's Cognitive Examination-III in Three Indian Languages: An Adaptation and Validation Study.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2024
Same journal

Global epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Assessment of Social Transmission of Food Preferences Behaviors
04:56

Assessment of Social Transmission of Food Preferences Behaviors

Published on: January 25, 2018

Utilisation behaviour in frontotemporal dementia.

Amitabha Ghosh1, Aparna Dutt

  • 1Department of Neurology, Apollo Gleneagles Hospitals, 58 Canal Circular Road, Kolkata 700054, India. amitabha.ghosh@yahoo.co.in

Journal of Neurology, Neurosurgery, and Psychiatry
|February 11, 2010
PubMed
Summary
This summary is machine-generated.

Utilisation behaviour (UB) is common in frontotemporal dementia (FTD) patients, often linked to daily objects and premorbid habits. This behaviour was not observed in Alzheimer's disease patients, suggesting UB as a potential indicator for FTD diagnosis.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

Assessment of Social Transmission of Food Preferences Behaviors
04:56

Assessment of Social Transmission of Food Preferences Behaviors

Published on: January 25, 2018

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

Area of Science:

  • Neuroscience
  • Neurology
  • Psychiatry

Background:

  • Frontotemporal dementia (FTD) is a neurodegenerative disorder.
  • Utilisation behaviour (UB) is a poorly understood phenomenon.
  • Previous research has not fully elucidated the prevalence of UB in FTD.

Purpose of the Study:

  • To investigate the occurrence and characteristics of utilisation behaviour (UB) in patients diagnosed with frontotemporal dementia (FTD).
  • To compare the incidence of UB in FTD patients with that in patients suffering from probable Alzheimer's disease (AD).

Main Methods:

  • Twenty FTD patients meeting consensus criteria and 34 probable AD patients were assessed by a neurologist and neuropsychologist.
  • Caregiver questionnaires and direct patient interviews using common objects were employed to gather behavioural data.
  • Imaging confirmed frontal or frontotemporal involvement in FTD patients; only frank and coherent UB was considered.

Main Results:

  • 80% of FTD patients exhibited utilisation behaviour (UB), while none of the Alzheimer's disease patients did.
  • Most FTD patients with UB (88%) displayed 'incidental' UB, frequently triggered by daily objects and often reflecting premorbid habits (75%).
  • UB was more prevalent in FTD patients under 70 years old.

Conclusions:

  • Utilisation behaviour (UB) appears to be a more frequent symptom in frontotemporal dementia (FTD) than previously recognized.
  • UB should be actively screened for in patients suspected of having FTD.
  • A detailed questionnaire, like the one utilized, can aid in identifying UB in clinical settings.